These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21374644)

  • 21. Inhibition of hepatocyte lipogenesis by nitric oxide donor: could nitric oxide regulate lipid synthesis?
    Roediger WE; Hems R; Wiggins D; Gibbons GF
    IUBMB Life; 2004 Jan; 56(1):35-40. PubMed ID: 14992378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide coating polypropylene mesh increases angiogenesis and reduces inflammatory response and apoptosis.
    Prudente A; Favaro WJ; Reis LO; Riccetto CL
    Int Urol Nephrol; 2017 Apr; 49(4):597-605. PubMed ID: 28181115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of vinblastine on smooth muscle cells in vitro: evaluation of a therapeutic window for the treatment of restenosis.
    Gallagher H; Carroll WM; Rochev Y
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):399-407. PubMed ID: 20147845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
    Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
    J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro effects of nitric oxide donors on apoptosis and oxidative/nitrative protein modifications in ADP-activated platelets.
    Sener A; Egemen G; Cevik O; Yanikkaya-Demirel G; Apikoglu-Rabus S; Ozsavci D
    Hum Exp Toxicol; 2013 Mar; 32(3):225-35. PubMed ID: 23111882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of paclitaxel and nitric oxide as a novel treatment for the reduction of restenosis.
    Lin CE; Garvey DS; Janero DR; Letts LG; Marek P; Richardson SK; Serebryanik D; Shumway MJ; Tam SW; Trocha AM; Young DV
    J Med Chem; 2004 Apr; 47(9):2276-82. PubMed ID: 15084126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R; Krebs R; Baur R; Hombach V
    Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of nitric oxide on the cryopreservation of platelets].
    Lee JH; Kim JT; Cho YG
    Korean J Lab Med; 2008 Apr; 28(2):136-43. PubMed ID: 18458510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of exogenous nitric oxide on glucose uptake in skeletal muscle of normoglycaemic and diabetic rats.
    McGrowder D; Ragoobirsingh D; Brown P
    Med Sci Monit; 2006 Jan; 12(1):BR28-35. PubMed ID: 16369460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric Oxide Generation from Endogenous Substrates Using Metal-Organic Frameworks: Inclusion within Poly(vinyl alcohol) Membranes To Investigate Reactivity and Therapeutic Potential.
    Neufeld MJ; Lutzke A; Jones WM; Reynolds MM
    ACS Appl Mater Interfaces; 2017 Oct; 9(41):35628-35641. PubMed ID: 28976734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-nitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery.
    Seabra AB; de Souza GF; da Rocha LL; Eberlin MN; de Oliveira MG
    Nitric Oxide; 2004 Nov; 11(3):263-72. PubMed ID: 15566973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
    Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
    J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Polymer Hemocompatibility for Blood-Contacting Applications via
    Griffin L; Douglass M; Goudie M; Hopkins SP; Schmiedt C; Handa H
    ACS Appl Mater Interfaces; 2022 Mar; 14(9):11116-11123. PubMed ID: 35225600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-Nitrosoglutathione-Based Nitric Oxide-Releasing Nanofibers Exhibit Dual Antimicrobial and Antithrombotic Activity for Biomedical Applications.
    Douglass M; Hopkins S; Pandey R; Singha P; Norman M; Handa H
    Macromol Biosci; 2021 Jan; 21(1):e2000248. PubMed ID: 33021079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide donor improves healing if applied on inflammatory and proliferative phase.
    Amadeu TP; Seabra AB; de Oliveira MG; Monte-Alto-Costa A
    J Surg Res; 2008 Sep; 149(1):84-93. PubMed ID: 18374944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic antithrombotic effect of a combination of NO donor and plasma kallikrein inhibitor.
    Ikarugi H; Inoue A; Yamashita T; Tsuda Y; Okada Y; Ishii H; Yamamoto J
    Thromb Res; 2005; 116(5):403-8. PubMed ID: 16122553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Formation of platelets from cord blood CD34+ cells-derived megakaryocytes induced by S-nitrosoglutathione].
    Dai B; He J; Chen S; Liu JH; Qin F; Zhu FM; Yan LX
    Sheng Li Xue Bao; 2006 Oct; 58(5):490-3. PubMed ID: 17041735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
    Lee YK; Hyung Park J; Tae Moon H; Yun Lee D; Han Yun J; Byun Y
    Biomaterials; 2007 Mar; 28(8):1523-30. PubMed ID: 17157376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
    Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.